A new, powerful Citizen Portal experience is ready. Switch now

Connecticut mandates Medicaid coverage for FDA-approved sickle cell gene therapies

June 09, 2025 | Senate Bills, Passed Bills, 2025 Bills, Connecticut Legislation Bills, Connecticut

Subscribe

This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Connecticut mandates Medicaid coverage for FDA-approved sickle cell gene therapies
Connecticut enacts law to require Medicaid coverage of gene therapies for sickle cell disease.

View Bill

This article is based on a bill currently being presented in the state government—explore the full text of the bill for a deeper understanding and compare it to the constitution

View Bill